glp-1 agonist medications Agonists: A Comprehensive Overview List of GLP-1 Receptor Agonists
Description
In May, VCU researchers published a study in JAMA Network Open that suggested breast cancer patients who used GLP-1s had better outcomes than those who didn't take the medications

Weight Regain and Cardiometabolic Effects After Withdrawal of Semaglutide: The STEP 1 Trial Extension
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
A 2024 study led by Wang, Volkow, and colleagues examined two cohorts totaling over 682,000 individuals with either obesity or type 2 diabetes and found the risk of new alcohol use disorder diagnoses was about 50% lower among those taking semaglutide compared to other anti-obesity or diabetes medications (Wang et al., 2024a)

Rhythm Pharmaceuticals (RYTM) is also involved in peptidergic drugs for weight loss

Dulaglutide, like other GLP-1RAs, leads to weight loss or reduced gain alone or with non-insulin secretagogues [278]

Pharmacoepidemiol Drug Saf (2015) 24(10):101725
